OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AML classification in the year 2023: How to avoid a Babylonian confusion of languages
Sandra Huber, Constance Baer, Stephan Hütter, et al.
Leukemia (2023) Vol. 37, Iss. 7, pp. 1413-1420
Open Access | Times Cited: 41

Showing 26-50 of 41 citing articles:

Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies
Pasquale Niscola, Valentina Gianfelici, Gianfranco Catalano, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 6632-6658
Open Access | Times Cited: 1

The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms
Vishesh Khanna, Rong Lü, Jyoti Kumar, et al.
Leukemia Research (2023) Vol. 136, pp. 107433-107433
Closed Access | Times Cited: 4

Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia
Daniel J. Chandra, Curtis A. Lachowiez, Sanam Loghavi
Blood Reviews (2023) Vol. 64, pp. 101156-101156
Closed Access | Times Cited: 3

Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis
Masayuki Umeda, Jing Ma, Tamara Westover, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2

A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML
Wenxin Du, Zhimei Xia, Zebin Luo, et al.
Leukemia (2023) Vol. 37, Iss. 11, pp. 2286-2291
Closed Access | Times Cited: 2

Identification of Novel Genes Implicated in Acute Myeloid Leukemia Progression using Bioinformatics Analysis of Microarray Data
Hassan Aboudi Hassan Al-Sayegh, Reza Safaralizadeh
Research Square (Research Square) (2024)
Closed Access

Feasibility, accuracy, and usability analysis of MapAML, a first‐in‐class app for integrated diagnosis in acute myeloid leukemia
Thaís B. Moyen, Victoria Tomaz, Paulo Vidal Campregher
European Journal Of Haematology (2024) Vol. 112, Iss. 4, pp. 633-640
Closed Access

Molecular techniques in haematopathology: what and how?
Gaurav Chatterjee, Rong He, Nikhil Patkar, et al.
Histopathology (2024)
Open Access

Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient
Michael Heuser, Rabia Shahswar
Hematology (2024) Vol. 2024, Iss. 1, pp. 158-167
Closed Access

AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts
Davidson Zhao, Qianghua Zhou, Mojgan Zarif, et al.
Leukemia Research (2023) Vol. 134, pp. 107376-107376
Closed Access | Times Cited: 1

Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells
Sophie Kreissig, Roland Windisch, Christian Wichmann
Cells (2023) Vol. 13, Iss. 1, pp. 78-78
Open Access | Times Cited: 1

Previous Page - Page 2

Scroll to top